National Science Week is Australia’s annual celebration of science and technology, running each year in August. Each year, over one million people participate in more than 2000 events across the country. These events attract a wide audience from children to adults, and citizen scientists to professionals, encouraging a broader interest in scientific pursuits, and inspiring younger people to be fascinated by the world we live in.
In 2020 the program moved online to accommodate COVID-19 lockdown conditions in Victoria. Inspiring Victoria and the Royal Society of Victora held the Possible Impossibles online festival. This is an online series of events and activities aimed at exploring the frontiers of possibility, and ask what’s next for the human species.
Three CBNS members were asked what impossible challenge they are working to solve, and what’s next for their field? Read what they had to say below.
Dr Paulina Ramírez García
Postdoctoral Research Fellow, Monash University
“There are many scientists including myself in the world right now who are trying to create a pill that can effectively stop pain. Current painkillers are only effective for specific types of pain and there is a lot of people whose pain cannot be treated. The impossible now is to stop the, so far, unstoppable and untreatable pain.” Read More
Dr Eric Du
Postdoctoral Researcher, The University of New South Wales
“In my research, I’m working towards developing materials for the bioprinter (a printer that prints a small 3D cell model) that will allow for the accurate testing of a large number of chemical compounds for personalised cancer treatments. This will let us quickly find the most effective way of treating cancer in a patient.” Read More
PhD Candidate, University of South Australia
“Now that we know that bacteria can protect themselves from antibiotics by hiding inside our cells …. we have used nanoparticles to piggyback our antibiotics (referred to as nanoantibiotics) and transport them across our cells … therefore allowing the antibiotic to kill the bacteria that once remained shielded. This then prevents the issue of patients having recurrent infections.” Read More